Medicines And Healthcare Products Regulatory Agency

Type: Organization
Name: Medicines And Healthcare Products Regulatory Agency
First reported Sep 17 2014 - Updated Sep 18 2014 - 2 reports

Experimental brain tumour therapy considered for NHS fast track

A new immunotherapy for a form of brain cancer has become the first in the UK to be designated  a 'Promising Innovative Medicine' (PIM) as part of a scheme to speed up access to experimental new treatments."Time is vitally important and can mean the difference ... [Published Cancer Research UK - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Sevenoaks Chronicle published Investigation launched after teenage girl's painkiller overdose...

PROBE: Store bosses have launched an investigation after an apparent suicide attempt in the car parkComments (0)SUPERMARKET bosses are investigating after a teenage girl bought a large number of painkillers and took an overdose in its car park.A member ... [Published Sevenoaks Chronicle - Sep 18 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

NW Bio cancer therapy first in UK early access scheme

An experimental cancer jab being developed by US group Northwest Biotherapeutics is the first medicine to be approved for early use under the UK’s new fast-track access programme.The cell therapy DCVax-L has received the first ever 'Promising Innovative ... [Published Pharma Times - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Wockhardt chairman has no plans to sell its business

Habil KhorakiwalaWockhardt chairman Habil Khorakiwala , on Monday, said the company has no intention of selling its business .The statement comes at a point when various news reports had suggested that the company may sell off some of its assets. Some ... [Published DNA India - Sep 16 2014]
First reported Sep 14 2014 - Updated Sep 14 2014 - 1 reports

A free event for all those interested in medical apps (UK)

On Wednesday 17th September the Health Technology Forum in London is meeting again at Baker Botts’ head office at the back of the Bank of England to hear presentations from:Joe Hagan-Brown , Regulatory Affairs Specialist at the Medicines and Healthcare ... [Published Telecare Aware - Sep 14 2014]
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

Metropolitan Police launch investigation into hospital baby deaths

Police have launched a criminal investigation into the deaths of three babies who contracted an infection from a suspected contaminated drip, including one in Cambridge.Officers from the Metropolitan Police's Homicide and Major Crime Command are investigating ... [Published itv.com - Sep 13 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 6 reports

Consort Medical plc Surges After Announcing Deal With British American Tobacco plc

Consort Medical   (LSE: CSRT) has jumped by nearly 10% today, after the medical device company said that the Voke nicotine inhaler had received market authorisation from the UK’s Medicines and Healthcare products Regulatory Agency.This is big news for ... [Published Motley Fool UK - Sep 12 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 2 reports

MHRA and Novartis lead consortium to develop adverse drug reaction app

The drug industry and regulators have teamed up to develop a smartphone app to make the gathering and reporting of adverse drug reactions easier.The project, known as web-RADR, is looking to capitalise on the uptake of smartphones and social media, creating ... [Published In-Pharmatechnologist - Sep 08 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 2 reports

MHRA to explore use of smartphones and apps in drug reaction reporting

The Medicines and Healthcare products Regulatory Agency is heading up an extensive EU-wide project designed to explore new ways of quickening the capture of information on suspected adverse drug reaction.The project will focus its attention on the use ... [Published Pharmacy.Biz - Sep 05 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

“New Drug” Designations for New Therapeutic Entities: New Active Substance, New Chemical Entity, New Biological Entity, New Molecular Entity

Medicines and Healthcare products Regulatory Agency, 151 Buckingham Palace Road, London, SW1W 9SZ, U.K.‡ Organic Chemistry, Institute of Chemistry, The Hebrew University of Jerusalem, Philadelphia Building No. 201/205, Edmond J. Safra Campus, Jerusalem ... [Published Journal of Medicinal Chemistry - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 2 reports

Ajinomoto Althea Gains EU GMP Certification

Ajinomoto Althea, Inc. has received its European GMP certificate from the Medicines and Healthcare products Regulatory Agency (MHRA) following an on-site inspection on June 19, 2014 that resulted in no critical or major observations. The certification ... [Published Contract Pharma - Sep 03 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 2 reports

Claris Lifesciences shares up 3.5% on BSE

MUMBAI: Shares of drug firm Claris Lifesciences today rose by over 3.5 per cent as the company has received approval by the UK health regulator, Medicines and Healthcare products Regulatory Agency (MHRA) for its newly commissioned plant in Ahmedabad.Stock ... [Published Economic Times - Aug 21 2014]

Quotes

Life Sciences Minister George Freeman said: "This Promising Innovative Medicine designation is the first crucial step in accelerating access to new medicines, giving real hope to patients and their families."
Expert in life sciences Helen Cline of Pinsent Masons, the law firm behind Out-Law.com, said: "The EAMS sits alongside the existing early access and early licensing European framework but can be distinguished from existing compassionate use schemes as it is intended to facilitate accelerated licensing by the European Medicines Agency and rapid commissioning by NICE. However, it is disappointing that the scheme itself is unfunded and that currently there is no special fund to pay for these medicines once licensed although cancer treatments such as DCVax-L could qualify for funding under the Cancer Drugs Fund."
"By and large we have not received any critical observation from the MHRA. Other observations are there and we are correcting it. We will hope to get their responses in the next few quarters" said Khorakiwala
"I'm fairly confident that most e-cigarettes contain fewer toxins than conventional cigarettes, but the trouble is that without standards and without someone overseeing things then consumers can't be sure."

More Content

All (111) | News (104) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Still feeling the Vioxx pain [Published Pharmaceutical Journal - Sep 18 2014]
UAE: New Abu Dhabi Centre of Excellence to Prod... [Published IPS Inter Press Service - Sep 18 2014]
Sevenoaks Chronicle published Investigation lau... [Published Sevenoaks Chronicle - Sep 18 2014]
Experimental brain tumour therapy considered fo... [Published Cancer Research UK - Sep 18 2014]
Abu Dhabi lays foundation to make anti-cancer g... [Published Khaleej Times - Sep 17 2014]
Cancer cell treatment first to be classed 'prom... [Published Out-Law.com - Sep 17 2014]
New Abu Dhabi centre of excellence to produce f... [Published Dubai PR Network - Sep 17 2014]
Galen plans to sell “green whistle” inhalable p... [Published In-Pharmatechnologist - Sep 16 2014]
NW Bio cancer therapy first in UK early access ... [Published Pharma Times - Sep 16 2014]
War of wards: Yes campaign experts fear NHS pri... [Published Daily Record - Sep 16 2014]
Wockhardt chairman has no plans to sell its bus... [Published DNA India - Sep 16 2014]
Big tobacco’s nicotine inhaler approved by UK r... [Published Pharmaceutical Journal - Sep 15 2014]
Health24.com | Medicinal nicotine inhaler appro... [Published Health24 - Sep 15 2014]
A free event for all those interested in medica... [Published Telecare Aware - Sep 14 2014]
Metropolitan Police launch investigation into h... [Published itv.com - Sep 13 2014]
Detectives launch criminal investigation into '... [Published Mail Online UK - Sep 12 2014]
Criminal probe into baby's death [Published Chelmsford Weekly News - Sep 12 2014]
Consort Medical plc Surges After Announcing Dea... [Published Motley Fool UK - Sep 12 2014]
First Regulatory Authorisation for Voke(R) Nico... [Published Newswit.com - Sep 12 2014]
BAT's novel e-cigarette rival wins UK medical a... [Published Sharenet - Sep 12 2014]
New nicotine inhaler wins key approval [Published Business Weekly UK - Sep 12 2014]
Is this the world's first medically-approved 'c... [Published Telegraph - Sep 12 2014]
Consort Medical Says Voke Inhaler Gets Marketin... [Published Town Hall - Sep 12 2014]
Consort Medical : Says Voke Inhaler Gets Market... [Published 4 Traders - Sep 12 2014]
BAT nicotine inhaler licensed as medicinal prod... [Published CNBC - Sep 12 2014]
First Regulatory Authorisation for Voke® Nicoti... [Published WorldNetDaily - Sep 12 2014]
First Regulatory Authorisation for Voke® Nicoti... [Published Pettinga Financial Advisors - Sep 12 2014]
First Regulatory Authorisation for Voke® Nicoti... [Published PR Newswire: General Business - Sep 12 2014]
@MHRA: regulators could track #drug reactions v... [Published In-Pharmatechnologist - Sep 11 2014]
Eighth Delegated Legislation Committee - Draft ... [Published United Kingdom Parliament - Sep 10 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
First Regulatory Authorisation for Voke® Nicoti... [Published PR Newswire: General Business - Sep 12 2014]
LONDON, September 12, 2014 /PRNewswire/ --Kind Consumer today announced that it has received a product licence for the Company's proprietary nicotine inhaler (Voke Inhaler 0.45mg) for General Sale from the UK Medicines and Healthcare products Regulatory ...
UK MHRA approves Cbris Lifesciences’ new facility [Published PBR - News - Aug 22 2014]
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Claris Lifesciences’ newly commissioned facility (Plant 2). ...
UK says Mylan recalls batches of Indian-made an... [Published Yahoo! Health News - Jun 18 2014]
U.S. drugmaker Mylan is recalling batches of the injectable antibiotic clarithromycin made in India due to possible impurities, Britain's healthcare regulator said on Wednesday. The Medicines and Healthcare products Regulatory Agency, or MHRA... ...
This week: Petards Fit for Growth, Galasys off ... [Published Proactiveinvestors United Kingdom website - Apr 03 2014]
BILL debt reduction,CCE award,CHRR trading update,ECK payment contracts,Galasys Intention to float on AIM,Haydale Graphene Industries Intention to float on AIM,PPT Pay in Your Currency,PEG final results,RAME Energy Intention to float on AIM,RENE UK regulatory ...
e-Therapeutics announces recruitment resumes in... [Published PBR - News - Mar 27 2014]
e-Therapeutics has announced that it has received approval from Medicines and Healthcare products Regulatory Agency (MHRA) to recommence recruitment of new patients into its ETS2101 Phase Ia solid tumors trial being conducted at three centers in the ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.